|
1）Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126: 663-76
|
|
|
|
2）Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007; 318: 1917-20
|
|
|
|
|
|
3）Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131: 861-72
|
|
|
|
|
|
4）Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature. 1981; 292: 154-6
|
|
|
|
|
|
5）Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A. 1981; 78: 7634-8
|
|
|
|
|
|
6）Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282: 1145-7
|
|
|
|
|
|
7）Dimos JT, Rodolfa KT, Niakan KK, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science. 2008; 321: 1218-21
|
|
|
|
|
|
8）Park IH, Arora N, Huo H, et al. Disease-specific induced pluripotent stem cells. Cell. 2008; 134: 877-86
|
|
|
|
|
|
9）Saha K, Jaenisch R. Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell. 2009; 5: 584-95
|
|
|
|
|
|
10）D’Amour KA, Bang AG, Eliazer S, et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol. 2006; 24: 1392-401
|
|
|
|
|
|
11）Saxen L. Organogenesis of the kidney. Cambridge: Cambridge University Press; 1987
|
|
|
|
|
|
12）Dressler GR. Advances in early kidney specification, development and patterning. Development. 2009; 136: 3863-74
|
|
|
|
|
|
13）Osafune K, Takasato M, Kispert A, et al. Identification of multipotent progenitors in the embryonic mouse kidney by a novel colony-forming assay. Development. 2006; 133: 151-61
|
|
|
|
|
|
14）Kobayashi A, Valerius MT, Mugford JW, et al. Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development. Cell Stem Cell. 2008; 3: 169-81
|
|
|
|
|
|
15）Cheng HT, Kim M, Valerius MT, et al. Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron. Development. 2007; 134: 801-11
|
|
|
|
|
|
16）Nakai S, Sugitani Y, Sato H, et al. Crucial roles of Brn1 in distal tubule formation and function in mouse kidney. Development. 2003; 130: 4751-59
|
|
|
|
|
|
17）Osafune K. iPS cell technology-based research for the treatment of diabetic nephropathy. Semin Nephrol. 2012; 32: 479-85
|
|
|
|
|
|
18）Yamamoto M, Cui L, Johkura K, et al. Branching ducts similar to mesonephric ducts or ureteric buds in teratomas originating from mouse embryonic stem cells. Am J Physiol Renal Physiol. 2006; 290: F52-60
|
|
|
|
|
|
19）Kobayashi T, Tanaka H, Kuwana H, et al. Wnt4-transformed mouse embryonic stem cells differentiate into renal tubular cells. Biochem Biophys Res Commun. 2005; 336: 3527-34
|
|
|
|
|
|
20）Kim D, Dressler GR. Nephrogenic factors promote differentiation of mouse embryonic stem cells into renal epithelia. J Am Soc Nephrol. 2005; 16: 3527-34
|
|
|
|
|
|
21）Morizane R, Monkawa T, Itoh H. Differentiation of murine embryonic stem cells and induced pluripotent stem cells to renal lineage in vitro. Biochem Biophys Res Commun. 2009; 390: 1334-9
|
|
|
|
|
|
22）Ren X, Zhang J, Gong X, et al. Differentiation of murine embryonic stem cells toward renal lineages by conditioned medium from ureteric bud cells in vitro. Acta Biochim Biophys Sin (Shanghai). 2010; 42: 464-71
|
|
|
|
|
|
23）Nishikawa M, Yanagawa N, Kojima N, et al. Stepwise renal lineage differentiation of mouse embryonic stem cells tracing in vivo development. Biochem Biophys Res Commun. 2012; 417: 897-902
|
|
|
|
|
|
24）Morizane R, Monkawa T, Fujii S, et al. Kidney specific protein-positive cells derived from embryonic stem cells reproduce tubular structures in vitro and differentiate into renal tubular cells. PLoS One. 2013; 8: e64843
|
|
|
|
|
|
25）Vigneau C, Polgar K, Striker G, et al. Mouse embryonic stem cell-derived embryoid bodies generate progenitors that integrate long term into renal proximal tubules in vivo. J Am Soc Nephrol. 2007; 18: 1709-20
|
|
|
|
|
|
26）Bruce SJ, Rea RW, Steptoe AL, et al. In vitro differentiation of murine embryonic stem cells toward a renal lineage. Differentiation. 2007; 75: 337-49
|
|
|
|
|
|
27）Mae S, Shirasawa S, Yoshie S, et al. Combination of small molecules enhances differentiation of mouse embryonic stem cells into intermediate mesoderm through BMP7-positive cells. Biochem Biophys Res Commun. 2010; 393: 877-82
|
|
|
|
|
|
28）Schuldiner M, Yanuka O, Itskovitz-Eldor J, et al. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A. 2007; 97: 11307-12
|
|
|
|
|
|
29）Batchelder CA, Lee CI, Matsell DG, et al. Renal ontogeny in the rhesus monkey (Macaca mulatta）and directed differentiation of human embryonic stem cells towards kidney precursors. Differentiation. 2009; 78: 45-56
|
|
|
|
|
|
30）Narayanan K, Schumacher KM, Tasnim F, et al. Human embryonic stem cells differentiate into functional renal proximal tubular-like cells. Kidney Int. 2013; 83: 593-603
|
|
|
|
|
|
31）Song B, Smink AM, Jones CV, et al. The directed differentiation of human iPS cells into kidney podocytes. PLoS One. 2012; 7: e46453
|
|
|
|
|
|
32）Mugford JW, Sipilä P, McMahon JA, et al. Osr1 expression demarcates a multi-potent population of intermediate mesoderm that undergoes progressive restriction to an Osr1-dependent nephron progenitor compartment within the mammalian kidney. Dev Biol. 2008; 324: 88-98
|
|
|
|
|
|
33）Mae S, Shono A, Shiota F, et al. Monitoring and robust induction of nephrogenic intermediate mesoderm from human pluripotent stem cells. Nat Commun. 2013; 4: 1367
|
|
|
|
|
|
34）Chen S, Borowiak M, Fox JL, et al. A small molecule that directs differentiation of human ESCs into the pancreatic lineage. Nat Chem Biol. 2009; 5: 258-65
|
|
|
|
|
|
35）Grskovic M, Javaherian A, Strulovici B, et al. Nat Rev Drug Discov. 2011; 10: 915-29
|
|
|
|
|
|
36）Ebert AD, Yu J, Rose FF Jr, et al. Induced pluri-potent stem cells from a spinal muscular atrophy patient. Nature. 2009; 457: 277-80
|
|
|
|
|
|
37）Brennand KJ, Simone A, Jou J, et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature. 2011; 473: 221-5
|
|
|
|
|
|
38）Egawa N, Kitaoka S, Tsukita K, et al. Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci Transl Med. 2012; 4: 145ra104
|
|
|
|
|
|
39）Yusa K, Rashid ST, Strick-Marchand H, et al. Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells. Nature. 2011; 478: 391-4
|
|
|
|
|
|
40）Thatava T, Armstrong AS, De Lamo JG, et al. Successful disease-specific induced pluripotent stem cell generation from patients with kidney transplantation. Stem Cell Res Ther. 2011; 2: 48
|
|
|
|
|
|
41）Israel MA, Yuan SH, Bardy C, et al. Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells. Nature. 2012; 482: 216-20
|
|
|
|
|
|
42）Kim C, Wong J, Wen J, et al. Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs. Nature. 2013; 494: 105-10
|
|
|
|
|